Ovarian cancer: new thoughts on an old problem.
Although survival in ovarian cancer remains poor, the use of paclitaxel and interval debulking surgery are now recognized to prolong survival. Future trials addressing the role of surgery, novel applications of chemotherapy, and screening, along with care by recognized specialists, may well improve outcome.